acc00301 |
GRB2-associated-binding protein 1 |
phosphorylation |
Tyr659 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00302 |
Receptor-interacting serine/threonine-protein kinase 1 |
phosphorylation |
Tyr384 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00303 |
Protein scribble homolog |
phosphorylation |
Tyr1268 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00304 |
Src substrate cortactin |
phosphorylation |
Tyr154 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00305 |
Src substrate cortactin |
phosphorylation |
Tyr302 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00306 |
Plectin |
phosphorylation |
Tyr4615 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00307 |
SH2 domain-containing adapter protein B |
phosphorylation |
Tyr114 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00308 |
Mitogen-activated protein kinase 14 |
phosphorylation |
Tyr182 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00309 |
Occludin |
phosphorylation |
Tyr337 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00310 |
Uncharacterized protein C6orf132 |
phosphorylation |
Tyr1017 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00311 |
Ragulator complex protein LAMTOR1 |
phosphorylation |
Tyr40 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00312 |
Pleckstrin homology domain-containing family A member 7 |
phosphorylation |
Tyr656 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00313 |
Phostensin |
phosphorylation |
Tyr230 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00314 |
Myosin phosphatase Rho-interacting protein |
phosphorylation |
Tyr450 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Positive |
5.0 |
PXD031346
|
acc00315 |
TRIO and F-actin-binding protein |
phosphorylation |
Tyr1854 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Positive |
5.0 |
PXD031346
|
acc00316 |
Protein MTSS 2 |
phosphorylation |
Tyr527 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00317 |
"Sprouty-related, EVH1 domain-containing protein 2" |
phosphorylation |
Tyr251 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00318 |
Lipolysis-stimulated lipoprotein receptor |
phosphorylation |
Tyr535 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00319 |
Lipolysis-stimulated lipoprotein receptor |
phosphorylation |
Tyr372 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00320 |
Mitotic interactor and substrate of PLK1 |
phosphorylation |
Tyr95 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00321 |
Mitotic interactor and substrate of PLK1 |
phosphorylation |
Tyr350 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00322 |
Mitotic interactor and substrate of PLK1 |
phosphorylation |
Tyr673 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00323 |
Rho GTPase-activating protein 12 |
phosphorylation |
Tyr243 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00324 |
Partitioning defective 3 homolog |
phosphorylation |
Tyr388 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00325 |
Partitioning defective 3 homolog |
phosphorylation |
Tyr199 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00326 |
LIM domain only protein 7 |
phosphorylation |
Tyr1430 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00327 |
"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1" |
phosphorylation |
Tyr1161 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00328 |
Kin of IRRE-like protein 1 |
phosphorylation |
Tyr625 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00329 |
Erbin |
phosphorylation |
Tyr1104 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00330 |
Plakophilin-4 |
phosphorylation |
Tyr1115 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00331 |
Plakophilin-4 |
phosphorylation |
Tyr494 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00332 |
Palmitoyltransferase ZDHHC5 |
phosphorylation |
Tyr456 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00333 |
Semaphorin-4C |
phosphorylation |
Tyr789 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00334 |
Band 4.1-like protein 1 |
phosphorylation |
Tyr864 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00335 |
Tight junction protein ZO-2 |
phosphorylation |
Tyr261 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00336 |
Tight junction protein ZO-2 |
phosphorylation |
Tyr269 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00337 |
Plakophilin-3 |
phosphorylation |
Tyr176 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00338 |
Plakophilin-3 |
phosphorylation |
Tyr84 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00339 |
Insulin receptor substrate 2 |
phosphorylation |
Tyr742 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00340 |
2-hydroxyacyl-CoA lyase 2 |
oxidation |
Met138 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00341 |
2-hydroxyacyl-CoA lyase 2 |
oxidation |
Met288 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00342 |
"Nascent polypeptide-associated complex subunit alpha, muscle-specific form" |
oxidation |
Met2048 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00343 |
Insulin-like growth factor 2 mRNA-binding protein 3 |
oxidation |
Met453 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00344 |
Insulin-like growth factor 2 mRNA-binding protein 1 |
oxidation |
Met453 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00345 |
Insulin-like growth factor 2 mRNA-binding protein 2 |
oxidation |
Met475 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00346 |
Pescadillo homolog |
oxidation |
Met273 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00347 |
Nucleolar protein 56 |
oxidation |
Met425 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00348 |
Nucleolar protein 56 |
oxidation |
Met236 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00349 |
Nucleolar protein 56 |
oxidation |
Met289 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|
acc00350 |
Stearoyl-CoA desaturase |
oxidation |
Met38 |
human |
Liver Cancer |
HepG2 |
Algae extract |
Negative |
5.0 |
PXD041686
|